PAVM

PAVmed Inc. (NASDAQ:PAVM) is a diversified medical device and digital health company founded in 2014 and headquartered in New York. The company has evolved from a traditional medical device developer into a holding company structure with multiple independently financed subsidiaries. PAVmed operates through three primary segments: Lucid Diagnostics (focused on esophageal cancer screening), Veris Health (digital health platform for cancer care), and PMX Incubator (early-stage medical device development). The company went public in 2016 and has since transitioned to a model where each subsidiary seeks independent financing while leveraging shared corporate infrastructure.